AR and prostate cancer: We also identified somatic mutations that altered the forkhead domain and the N-terminal transactivation domain of the AR cofactor FOXA1. Four samples were positive for the HOXB13 p.G84E germline variant that has been associated with prostate cancer susceptibility [20], including one homozygous sample.